The current SER market cap is 41.12M. The company's latest EPS is USD -1.6667 and P/E is -2.90.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 9k | 67k | 56k | 5k | 51k |
Operating Income | -1.89M | -2.36M | -3.56M | -2.32M | -3.87M |
Net Income | -2.67M | -5.4M | -3.46M | -9.44M | -374k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.73M | 1.87M | 144k | 34k | 142k |
Operating Income | -12.56M | -10.67M | -8.04M | -6.98M | -9.96M |
Net Income | -12.15M | -10.87M | -8.68M | -10.46M | -14.8M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 12.28M | 12.21M | 11.97M | 10.86M | 10.71M |
Total Liabilities | 34.57M | 3.9M | 6.61M | 15.17M | 27.1M |
Total Equity | -22.3M | -27.65M | 5.36M | -4.31M | -16.39M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 7.44M | 3.93M | 3.15M | 3.24M | 11.97M |
Total Liabilities | 4.83M | 9.32M | 15.03M | 20.56M | 6.61M |
Total Equity | 2.62M | -5.4M | -11.88M | -17.32M | 5.36M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -3.88M | -5.75M | -7.8M | -1.58M | -9.59M |
Investing | -10M | -10M | -10M | -14k | -14k |
Financing | 13.5M | 15.5M | 17.5M | 2.73M | 8.1M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -10.16M | -7.82M | -7.86M | -5.94M | -7.8M |
Investing | -361k | -20k | 666k | N/A | -10M |
Financing | 6.27M | 5.96M | 7.25M | 6M | 17.5M |
Market Cap | 41.12M |
Price to Earnings Ratio | -2.90 |
Price to Sales Ratio | 301.88 |
Price to Cash Ratio | 124.48 |
Price to Book Ratio | 8.01 |
Dividend Yield | - |
Shares Outstanding | 8.88M |
Average Volume (1 week) | 18.79k |
Average Volume (1 Month) | 17.29k |
52 Week Change | -60.36% |
52 Week High | 19.93 |
52 Week Low | 3.81 |
Spread (Intraday) | 1.94 (30.12%) |
Company Name | Serina Therapeutics Inc |
Address |
108 lakeland ave dover, delaware 19901 |
Website | https://serinatherapeutics.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.